Your Messages Inbox (0) 
Your Unread Messages
See AllMost Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Effects of combination therapy with verteporfin photodynamic therapy and ranibizumab in patients with age-related macular degeneration
Acta Ophthalmologica, 11/06/09
Wolf–Schnurrbusch UEK et al. – There were no visual safety concerns and intraocular pressures remained normal. Only two serious adverse events were recorded over the 12–month period, and neither was considered to be related to treatment. Same–day verteporfin plus ranibizumab improved VA, reduced CRT, prevented CNV perfusion and reduced lesion area safely over 12 months.
Related Articles
Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration
Retina, 11/11/09
Relevance Score: 68%
Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial
Ophthalmology, 10/28/09
Relevance Score: 68%
siRNA therapeutics for age-related macular degeneration: promises and pitfalls
Expert Review of Ophthalmology, 10/22/09
Relevance Score: 68%
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Relevance Score: 67%
Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections
Acta Ophthalmologica, 11/11/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Infliximab and anterior optic neuropathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/23/09
Retinal Arteriolar Vascular Reactivity in Untreated and Progressive Primary Open Angle Glaucoma
Investigative Ophthalmology and Visual Science, 11/20/09
"Treat and Extend" Dosing of Intravitreal Antivascular Endothelial Growth Factor Therapy for Type 3 Neovascularization/Retinal Angiomatous Proliferation
Retina, 11/20/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Adenovirus Vectors Targeting Distinct Cell Types in the Retina
Investigative Ophthalmology and Visual Science, 11/23/09
Choroidal Thickness in Healthy Japanese Subjects
Investigative Ophthalmology and Visual Science, 11/23/09
Drusen deposits contain soluble and mature amyloid fibrils
Investigative Ophthalmology and Visual Science, 11/23/09
Article Search
Sponsor